abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc., headquartered in Philadelphia, Pennsylvania. The fund invests in public equity markets globally with a primary focus on the healthcare sector, including biotechnology, medical devices, and pharmaceuticals. Its portfolio concentrates on small-cap growth stocks, employing fundamental analysis that evaluates factors such as market positioning, management quality, technological capabilities, and financial sustainability.

The fund's investment strategy emphasizes companies with strong competitive advantages and the capacity to self-fund growth or secure external capital. Performance is benchmarked against three indices: the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. The fund was established in October 1986 and operates as a United States-domiciled investment vehicle. Abrdn Inc., the fund manager, is part of the broader abrdn group, a global asset management firm operating across multiple geographies and asset classes.